Pacific Biosciences Accuracy Notes
| Date | Overall | Insertions | Deletions | Substitutions | Read Length | Ref | |
| PacBio RS II | ~2013 | ~11% | “predominantly indel” | “predominantly indel” | “predominantly indel” | Vendor | |
| PacBio RS II | 2020 | ~13% | 8% | 3% | 1.68% | Academic Benchmark | |
| PacBio RS II CLR | 2020 | 12.88% | 8.04% | 3.16% | 1.68% | 8899 | Academic Benchmark |
| PacBio RS II Subread | 2017 | 14.2% | 5.92% | 3.01% | 5.27% | Academic Benchmark | |
| PacBio Sequel I CLR | 2019 | 12% | Inferred from Vendor Claim | ||||
| PacBio Sequel II CLR | 2019 | 10% | ~50Kb | Inferred from Vendor Claim | |||
| Revio (Subread) | 2023 | 10% | All: 100Kb+? | Inferred from Vendor Claim | |||
| PacBio RS II CCS | 2017 | 1.72 | 0.087% | 0.34% | 1.3% | 1772 | Academic Benchmark |
| PacBio Sequel HiFi | 2022 | 0.25% | 0.1% | 0.13% | 0.02% | Academic Note | |
| PacBio Sequel II CCS | 2019 | 0.14% | Academic Benchmark | ||||
| PacBio Sequel II HiFi | 2019 | <0.1% | 20Kb | Vendor Claim | |||
| Revio (All HiFi) | 2023 | <0.1% | 16.5Kb | Vendor Claim |
RSS